Skip to search formSkip to main contentSkip to account menu

mesoglycan

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
2015
2015
AIM Chronic venous disorders (CVDs) subtend a spectrum of vascular abnormalities, including microcirculation and skin damages (as… 
2003
2003
40 subjects who had a transitory ischemic cerebral attack were treated with Mesoglycan and controlled for two consecutive years… 
1999
1999
BACKGROUND Aim of the present comparative clinical study was to demonstrate the efficacy of the topical application of mesoglycan… 
1997
1997
BACKGROUND Mesoglycan is a natural glycosaminoglycans preparation, with antithrombotic and pro-fibrinolytic activities, which has… 
1995
1995
The aim of this randomized, open, parallel-group study was to compare the efficacy and tolerability of mesoglycan, a… 
1994
1994
Heparin and heparan sulfate proteoglycans (HSPGs) stabilize FGFs which belong to heparin-binding growth factors (HBGFs) on active… 
1994
1994
Forty-four patients with intermittent claudication were included and randomised in two groups respectively treated with oral… 
1993
1993
Background. Cutaneous necrotizing venulitis (CNV) is a clinical disorder associated with segmental inflammation and fibrinoid… 
1993
1993
The present study evaluates the hematochemical and hemorheologic effects of mesoglycan, a preparation of natural…